The emerging treatment of the medication represents a major advance in the management of the condition. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide753233.blogdeazar.com/42468831/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment